Kimber Simmons

14PUBLICATIONS
82CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Gene and molecular therapyInfant and child healthAboriginal and Torres Strait Islander youth and family social and emotional wellbeingMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 24, 2026
Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter].

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Jan 14, 2026
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.

Kagan E Karakus, Lexie Chesshir, Sonya Walker

|Nov 06, 2025
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Oct 27, 2025
Children's Understanding of Risk for Type 1 Diabetes: The TEDDY Study.

Holly O'Donnell, Roy Tamura, Laura Smith

|Feb 14, 2025
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes.

Holly K O'Donnell, Kimber M Simmons, Stephen E Gitelman

|Feb 11, 2025
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].

Moshe Phillip, Peter Achenbach, Ananta Addala

Pageof 3

Frequent Collaborators

6 joint publications

Holly O'Donnell

6 joint publications

Linda A DiMeglio

5 joint publications

Andrea K Steck

4 joint publications

Ezio Bonifacio